As in the world, cancer is an increasingly important health problem in our country. The most common cancers in our country are breast, lung, large intestine, rectum, cervix, ovary, stomach, and pancreas in women; lung, prostate, large intestine, rectum, stomach and pancreas.
Medical oncology is a top specialty of internal diseases and has an important role in the coordination of cancer patients. The approach to diagnosis and treatment of cancer patients is possible with the decision of all units related to the disease. One of the most important tasks of medical oncology is planning and application of drug treatment. Cancer medication is determined according to the type of cancer, the stage of the disease, the pathological characteristics of the cancer cell, the genetic changes that occur in cancer cells, the age, concomitant disease and performance of the patient. For this evaluation, treatment plan and drug selection are carried out by cooperating with other branches. Today, cancer drug treatment varies according to each patient, which means personalization.
There are various group drugs in the treatment of cancer. The first group is "chemotherapy drugs" for the destruction of cancer cells. The second group is çoğ targeted drugs ı that prevent the survival and proliferation of cancer cells by disrupting the mechanisms that promote the growth and proliferation of cancer cells. In addition, the hormone-sensitive cancer types (breast, prostate cancer, such as) "hormone-resistant drugs" is. Another group is "support drugs". They are also used against adverse events caused by the disease as well as side effects associated with treatment. Recently, there are immunotherapy drugs that strengthen the immune system and strengthen the patient's fight with cancer. The drugs used in the treatment of cancer vary according to the purpose.
In addition to surgical treatment in the early stages of the disease, it can be applied to eliminate the microscopic disease in high-risk patients after surgery. It can also be used to reduce the reduction and spread of the tumor prior to surgery. In some cases, radiotherapy can be performed simultaneously or before or after radiotherapy during radiotherapy. It is aimed to completely eliminate the disease when applied with local treatments in early non-spread diseases.
Chemotherapy, targeted medications, or both may be administered together to control disease, prevent proliferation, and prolong life expectancy in advanced or recurrent disease states. In this process, the aim is to prevent the disease from becoming a chronic disease and damaging the patient. Surgery may also be added for residual tumors in some patients who are controlled by drug therapy in this stage.
Personalized Treatment Plan
Department of Medical Oncology includes breast cancer, lung cancer, gastrointestinal cancers, pancreatic cancer, liver cancer, gallbladder and cancers of cancer, ovarian cancer, cervical cancer, uterine cancer, head and neck tumors, osteosarcoma and soft tissue sarcomas, brain tumors, kidney bladder cancer, prostate cancer, testicular cancer, malignant melanoma, lymphoma, thyroid cancer, such as the diagnosis, treatment and follow-up process provides many types of cancer.
In the Department of Medical Oncology, specialists conduct the follow-up and treatment of cancer patients. They act together with all branches related to this process. The optimal treatment approaches are planned for patients in the Tumor Council. All kinds of chemotherapy, targeted therapies, hormone therapy, immunotherapy and cancer support therapies are planned by medical oncology specialists for each patient and applied by an experienced team. These applications are usually daily therapy. Inpatient treatment may also be provided if necessary or desired.